CEL-SCI
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Virginia, United States · Employees
View Company Info for Free
Overview
Headquarters
8229 Boone Blvd Ste 802, Vienna, Virgini...Phone Number
(703) 506-9460Website
www.cel-sci.comRevenue
-Stock Symbol
CVMIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About CEL-SCI
CEL-SCI was founded in 1983, and is headquartered in Vienna, Virginia. CEL-SCI is involved in the research and development of immunotherapy products for the treatment of cancer, autoimmune and infectious diseases.Explore more
CEL-SCI Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CEL-SCI your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
CEL-SCI, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if CEL-SCI had a recent Job posting/layoffs
Earning: See what the market has to say on CEL-SCI recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if CEL-SCI is spiking on competitors!
Funding: Get notified immidiatlly once CEL-SCI has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at CEL-SCI
Check if CEL-SCI has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when CEL-SCI launches new products
Recommended Actions
Find VP level buyers at CEL-SCI
Find 3 more new buyers
Compare Similar Companies to CEL-SCI
Compare insights from companies similar to CEL-SCI, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CEL-SCI is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CEL-SCI is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CEL-SCI.
CEL-SCI financials insights
Gather financial insights about CEL-SCI, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Stock Offering
$14.7M
2021
Stock Offering
$31.7M
2026
Stock/Share Issuance
$7.2M
CEL-SCI Tech Stack
A closer look at the technologies used by CEL-SCI
Most Recent Scoops
Funding
Funding
Project
, according to a mid-level source in operations management, is in the midst of initiatives related to accounting and finance software. The organization is currently evaluating QuickBooks Desktop Pro and Sage50, QuickBooks Enterprise, and QuickBooks Online. CEL-SCI will be increasing funding and is expected to increase contingent workforce to support these efforts.
Spending/Investment, Contingent Workforce, Accounting, Financial Planning, Funding, Desktop, Financial Systems, Software, Financial Reporting, Finance, Operations
Project
, according to a mid-level source in operations management, is planning to begin initiatives related to project, portfolio, and program management software within three months. The organization is currently evaluating ClickUp, Smartsheet, and Wrike. Microsoft 365 is being utilized in this area.
Enterprise Software, Software, Workforce Management, Operations
Project
, according to a mid-level source in operations management, is planning to begin initiatives related to business process management (BPM) within three to six months. The organization is currently evaluating Kissflow, Ninox, and ProcessMaker.
Analytics & Insights, Workforce Management, Corporate Strategy, Operations
Project
Digital Transformation, Operations
CEL-SCI News & Media
CEL-SCI Corporation Nears Key Commercial Milestones - WebDisclosure
First Berlin Equity Research updates BUY recommendation for CEL-SCI Corp. following key developments in Saudi Arabia and US. Price target revised to USD 60CEL-SCI to Sign Partnership Agreement With Leading Saudi Arabian Pharma Company for Multikine in the Treatment of Head & Neck Cancer
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI to sign partnership agreement with leading Saudi Arabian pharma company for Multikine in the treatment of head & neck cancer.CEL-SCI Announces Closing of Public Offering
VIENNA, Va.--(BUSINESS WIRE)---- $CVM--CEL-SCI announces closing of public offering.CEL-SCI Announces Pricing of Public Offering
VIENNA, Va.--(BUSINESS WIRE)---- $CVM--CEL-SCI announces pricing of public offering.
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding CEL-SCI
Sign Up For FreeTo access detailed company insights
CEL-SCI was founded in 1983, and is headquartered in Vienna, Virginia. CEL-SCI is involved in the research and development of immunotherapy products for the treatment of cancer, autoimmune and infectious diseases.... Read More
